ask="4.00"
ask_size="100"
average_daily_volume="240685"
bid="2.00"
bid_size="100"
book_value="3.15"
change="-0.01"
change_from_200_day_moving_average="-0.62"
change_from_50_day_moving_average="-0.25"
change_from_52_week_high="-6.24"
change_From_52_week_low="0.36"
change_in_percent="-0.49%"
close="2.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.70"
ebitda="-56.49M"
eps_estimate_current_year="-5.24"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="14677000"
high="2.17"
high_52_weeks="8.29"
last_trade_date="1/27/2017"
last_trade_price="2.05"
last_trade_size="3778"
last_trade_time="4:00pm"
low="2.02"
low_52_weeks="1.69"
market_capitalization="41.51M"
moving_average_200_day="2.67"
moving_average_50_day="2.30"
name="Aptevo Therapeutics Inc."
notes="N/A"
one_year_target_price="5.00"
open="2.07"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.28%"
percent_change_from_50_day_moving_average="-11.01%"
percent_change_from_52_week_high="-75.27%"
percent_change_from_52_week_low="+21.30%"
previous_close="2.06"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.65"
price_per_sales="1.16"
revenue="35.95M"
shares_outstanding="20248000"
short_ratio="2.06"
stock_exchange="NMS"
symbol="APVO"
volume="154461"
weeks_range_52="1.69 - 8.29"
